JUSOHI
LIVE

Serial Number

79226609

Owner

Novartis AG

Filing Date

Jan 11, 2018

Add to watchlist:

No watchlists yet
View on USPTO

JUSOHI Trademark

Serial Number: 79226609 • Registration: 5494792

JUSOHI is a trademark filed by Novartis AG on January 11, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Sandoz AG (3 trademarks)

Viaduktstrasse 3

Entity Type: 03

Trademark Details

Filing Date

January 11, 2018

Registration Date

June 19, 2018

Published for Opposition

April 3, 2018

Cancellation Date

January 3, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Feb 25, 2026 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Feb 25, 2026 INNA
GENERIC MADRID TRANSACTION CREATED
Feb 25, 2026 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 3, 2025 INTR
CANCELLED SECTION 71
Jan 3, 2025 C71T
CHANGE OF OWNER RECEIVED FROM IB
Jan 22, 2024 CHLD
NOTIFICATION PROCESSED BY IB
Feb 8, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Aug 3, 2018 FICS
FINAL DISPOSITION PROCESSED
Aug 3, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 19, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2018 R.PR
PUBLISHED FOR OPPOSITION
Apr 3, 2018 PUBO
NOTICE OF PUBLICATION
Mar 14, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2018 CNSA
ASSIGNED TO EXAMINER
Feb 26, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 16, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 9, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 8, 2018 SDRC